JeffreyStuartBrownMD

PubMed

• Evaluation of Use of Technologies to Facilitate Medical Chart Review.
  Straub, L.,Gagne, J. J.,Maro, J. C.,Nguyen, M. D.,Beaulieu, N.,Brown, J. S.,Kennedy, A.,Johnson, M.,Wright, A.,Zhou, L.,Wang, S. V.> ;Drug Saf. 2019 May 22
• Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network.
  Doria-Rose, V. P.,Greenlee, R. T.,Buist, DSM.,Miglioretti, D. L.,Corley, D. A.,Brown, J. S.,Clancy, H. A.,Tuzzio, L.,Moy, L. M.,Hornbrook, M. C.,Brown, M. L.,Ritzwolle...> ;EGEMS (Wash DC). 2019 Apr 12
• Graphical Depiction of Longitudinal Study Designs in Health Care Databases.
  Schneeweiss, S.,Rassen, J. A.,Brown, J. S.,Rothman, K. J.,Happe, L.,Arlett, P.,Dal Pan, G.,Goettsch, W.,Murk, W.,Wang, S. V.> ;Ann. Intern. Med.. 2019 Mar 12
• How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias.
  Platt, R. W.,Platt, R.,Brown, J. S.,Henry, D. A.,Klungel, O. H.,Suissa, S.> ;Pharmacoepidemiol Drug Saf. 2019 Jan 17
• The FDA Sentinel Initiative - An Evolving National Resource.
  Platt, R.,Brown, J. S.,Robb, M.,McClellan, M.,Ball, R.,Nguyen, M. D.,Sherman, R. E.> ;N. Engl. J. Med.. 2018 Nov 30
• Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings.
  Raman, S. R.,Brown, J. S.,Curtis, L. H.,Haynes, K.,Marshall, J.,Pawloski, P. A.,Platt, R.> ;J Gen Intern Med. 2018 Oct 24
• Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools.
  Sobel, R. E.,Bate, A.,Marshall, J.,Haynes, K.,Selvam, N.,Nair, V.,Daniel, G.,Brown, J. S.,Reynolds, R. F.> ;Pharmacoepidemiol Drug Saf. 2018 Feb 03
• Spending and quality of care for Medicare beneficiaries in Massachusetts.
  Brown, J.> ;JAMA. 2013 Dec 26
• Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer.
  Kim, S. C.,Gillet, V. G.,Feldman, S.,Lii, H.,Toh, S.,Brown, J. S.,Katz, J. N.,Solomon, D. H.,Schneeweiss, S.> ;Pharmacoepidemiol Drug Saf. 2013 Sep 12
• Data quality assessment for comparative effectiveness research in distributed data networks.
  Brown, J. S.,Kahn, M.,Toh, S.> ;Med Care. 2013 Aug
• Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care.
  Brown, J. S.,Holmes, J. H.,Shah, K.,Hall, K.,Lazarus, R.,Platt, R.> ;Med Care. 2010 May 18
• Active influenza vaccine safety surveillance: potential within a healthcare claims environment.
  Brown, J. S.,Moore, K. M.,Braun, M. M.,Ziyadeh, N.,Chan, K. A.,Lee, G. M.,Kulldorff, M.,Walker, A. M.,Platt, R.> ;Med Care. 2009 Sep 30
• Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations.
  Brown, J. S.,Kulldorff, M.,Petronis, K. R.,Reynolds, R.,Chan, K. A.,Davis, R. L.,Graham, D.,Andrade, S. E.,Raebel, M. A.,Herrinton, L.,Roblin, D.,Boudreau, D.,Smith, D...> ;Pharmacoepidemiol Drug Saf. 2009 Jan 17
• Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
  Brown, J. S.,Kulldorff, M.,Chan, K. A.,Davis, R. L.,Graham, D.,Pettus, P. T.,Andrade, S. E.,Raebel, M. A.,Herrinton, L.,Roblin, D.,Boudreau, D.,Smith, D.,Gurwitz, J. H...> ;Pharmacoepidemiol Drug Saf. 2007 Oct 24
• Migraine frequency and health utilities: findings from a multisite survey.
  Brown, J. S.,Neumann, P. J.,Papadopoulos, G.,Ruoff, G.,Diamond, M.,Menzin, J.> ;Value Health. 2008 Apr 03
• Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic.
  Brown, J. S.,Petronis, K. R.,Bate, A.,Zhang, F.,Dashevsky, I.,Kulldorff, M.,Avery, T. R.,Davis, R. L.,Chan, K. A.,Andrade, S. E.,Boudreau, D.,Gunter, M. J.,Herrinton, ...> ;Pharmaceutics. 2013 Dec 05
• Join now to see all